Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016927
Chunk: 79

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 79
---
 Common Warrants and the October 2024 Common Warrant Shares were not registered under the Securities Act and were instead offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder.

Pursuant to the terms of the October 2024 Purchase Agreement, we agreed not to enter into an agreement involving any Variable Rate Transaction (as defined in the October 2024 Purchase Agreement) until twelve (12) months following the closing of the October 2024 Offerings, provided however, that the prohibition on “at the market offerings” and equity lines of credit shall expire on April 21, 2025 (the six-month anniversary of the closing of the October 2024 Offerings). In addition, each of our officers and directors have entered into lock-up agreements with us pursuant to which each of them has agreed not to offer, sell, transfer or otherwise dispose of our securities, subject to certain exceptions, until April 22, 2025.

WallachBeth acted as the exclusive placement agent on a “reasonable best efforts” basis, in connection with the October 2024 Offerings pursuant to that certain placement agency agreement, dated October 18, 2024, by and between us and WallachBeth (the “October 2024 PAA”). Pursuant to the October 2024 PAA, WallachBeth received a cash fee of 8.0% of the aggregate gross proceeds paid to us for the securities sold in the October 2024 Offerings and reimbursement of certain out-of-pocket expenses up to a maximum of $75,000. As additional compensation to WallachBeth, in connection with the October 2024 Offerings, we issued to the designees of WallachBeth, the October 2024 PA Warrants to purchase an aggregate of 61,448 shares of Common Stock, which is equal to approximately 3.0% of the number of October 2024 Shares issued in the October 2024 RD, at an exercise price per share equal to $1.50, which is equal to the exercise price of the October 2024 Common Warrants. On April 30, 2025, the termination date of the October 2024 PA Warrants was changed to April 30, 2025, at which time such warrants were terminated, cancelled and no longer exercisable.

In addition, pursuant to the terms of the October 2024 PAA: (a) Wallach